Matthew Kurian, Executive Committee Member at KYSCO, shared on LinkedIn:
“You may not have heard of St. Elizabeth Healthcare. But you should know about the research happening here!
Some assume we’re a small community oncology practice. I’d like to say we are the future of oncology: a subspecialty specific, multiD, community/academic hybrid.
What they may not know: 30+ Phase I–III trials are open across our cancer program – with startup times often faster than major academic centers.
That happens because of an incredible research team.
I’m especially grateful for our veteran breast cancer research team – talented, experienced, and deeply committed to bringing cutting-edge trials to our patients close to home.
This Breast Cancer Awareness Month, a huge thank you to the entire team for everything you do.
‘World-class clinical research doesn’t require a world-famous address.’ “
To which, Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, added:
“Well-said Matt! Appreciate all the work that you do, truly above and beyond!”
Other articles about St. Elizabeth Healthcare on OncoDaily.